These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 13676790)

  • 1. Epidemiological effectiveness of anti-influenza monovalent vaccine A2.
    UNANOV SS; VASIL'EV LV; LEBEDEV AA
    Zh Mikrobiol Epidemiol Immunobiol; 1959 May; 30(5):31-7. PubMed ID: 13676790
    [No Abstract]   [Full Text] [Related]  

  • 2. Effectiveness of monovalent influenza A-prime vaccine during 1957 influenza A-prime epidemic.
    MEIKLEJOHN G
    Am J Hyg; 1958 Mar; 67(2):237-49. PubMed ID: 13520709
    [No Abstract]   [Full Text] [Related]  

  • 3. [Epidemiological effectiveness of live influenza vaccine during A2 and B influenza outbreaks in 1962].
    Smorodintsev AA; Dokuchaev GI; Minichev PN; Filippov NA; Chalkina OM
    Vopr Virusol; 1965; 10(4):476-82. PubMed ID: 5874477
    [No Abstract]   [Full Text] [Related]  

  • 4. Bivalent influenza vaccination with inactivated vaccines administered by nasal or oral route.
    Petrescu A; Mihail A; Popescu A; Cojiţă M; Sternberg I; Steiner N; Hondor C
    Virologie; 1976; 27(1):41-5. PubMed ID: 941402
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An experience with vaccination against influenza B in 1952 using monovalent vaccine.
    HENNESSY AV; MINUSE E; DAVENPORT FM; FRANCIS T
    AMA Am J Dis Child; 1953 Oct; 86(4):494. PubMed ID: 13091359
    [No Abstract]   [Full Text] [Related]  

  • 6. An experience with vaccination against influenza B in 1952 by use of monovalent vaccine.
    HENNESSY AV; MINUSE E; DAVENPORT FM; FRANCIS T
    Am J Hyg; 1953 Sep; 58(2):165-73. PubMed ID: 13080256
    [No Abstract]   [Full Text] [Related]  

  • 7. [Epidemiological effectiveness of influenza vaccine].
    UNANOV SS
    Vopr Virusol; 1957; 2(2):86-91. PubMed ID: 13443242
    [No Abstract]   [Full Text] [Related]  

  • 8. [Epidemiological efficacy of live influenza vaccine during the A2 and B influenza outbreaks in 1962].
    Smorodintsev AA; Dokuchaev GI; Minichev PN; Filippov NA; Chalkina OM
    Zh Mikrobiol Epidemiol Immunobiol; 1965 Oct; 42(10):54-61. PubMed ID: 4224565
    [No Abstract]   [Full Text] [Related]  

  • 9. [Principles and methods for vaccine epidemiology: evaluation of immunogenicity and effectiveness of pandemic H1N1 influenza vaccine].
    Hara M; Ohfuji S; Fukushima W; Hirota Y
    Nihon Eiseigaku Zasshi; 2013; 68(3):153-60. PubMed ID: 24077487
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Investigations on effectiveness of anti-influenza vaccine].
    SLEPUSHKIN AN; ANOFRIEV AS
    Zh Mikrobiol Epidemiol Immunobiol; 1955 Dec; (12):29-34. PubMed ID: 13300915
    [No Abstract]   [Full Text] [Related]  

  • 11. [Sero-epidemiological investigations of the effectiveness of influenza vaccine with attenuated live viruses of types A2 and B].
    Ivan A; Vancea G; Zvorişteanu V; Oană C; Rusu F; Gherman A; Meleghi M
    Stud Cercet Inframicrobiol; 1968; 19(5):355-61. PubMed ID: 5716054
    [No Abstract]   [Full Text] [Related]  

  • 12. Evaluation of monovalent and polyvalent influenza vaccines during an epidemic of type A2 and B influenza.
    Maynard JE; Dull HB; Hanson ML; Feltz ET; Berger R; Hammes L
    Am J Epidemiol; 1968 Jan; 87(1):148-57. PubMed ID: 5637865
    [No Abstract]   [Full Text] [Related]  

  • 13. Update on influenza A (H1N1) 2009 monovalent vaccines.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2009 Oct; 58(39):1100-1. PubMed ID: 19816398
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Studies with inactivated influenza vaccines purified by zonal centrifugation. 2. Efficacy.
    Schoenbaum SC; Mostow SR; Dowdle WR; Coleman MT; Kaye HS
    Bull World Health Organ; 1969; 41(3):531-5. PubMed ID: 5309468
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety of influenza A (H1N1) 2009 monovalent vaccines - United States, October 1-November 24, 2009.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2009 Dec; 58(48):1351-6. PubMed ID: 20010511
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevention and control of influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2010.
    Fiore AE; Uyeki TM; Broder K; Finelli L; Euler GL; Singleton JA; Iskander JK; Wortley PM; Shay DK; Bresee JS; Cox NJ;
    MMWR Recomm Rep; 2010 Aug; 59(RR-8):1-62. PubMed ID: 20689501
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Monovalent influenza A(H1N1) vaccine, 1986-1987. Recommendations of the Immunization Practices Advisory Committee. Centers for Disease Control, Department of Health and Human Services.
    Ann Intern Med; 1986 Nov; 105(5):737-9. PubMed ID: 3021040
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effectiveness of monovalent 2009 pandemic influenza A virus subtype H1N1 and 2010-2011 trivalent inactivated influenza vaccines in Wisconsin during the 2010-2011 influenza season.
    Bateman AC; Kieke BA; Irving SA; Meece JK; Shay DK; Belongia EA
    J Infect Dis; 2013 Apr; 207(8):1262-9. PubMed ID: 23341536
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The effectiveness of using the Vaxigrip vaccine from the firm of Pasteur Mérieux Connaught for influenza prevention in organized groups of adults].
    Sharipova IS; Fel'dblium IV; Kuz'minykh SI; Nikolova IV; Padrul' MM; Sharipov MS; Nikul'shin AA; Kol'tsova AA
    Zh Mikrobiol Epidemiol Immunobiol; 1999; (3):37-41. PubMed ID: 10851988
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Monovalent influenza A(H1N1) vaccine, 1986-1987.
    Centers for Disease Control (CDC)
    MMWR Morb Mortal Wkly Rep; 1986 Aug; 35(32):517-21. PubMed ID: 3090424
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.